ASTRAZENECA is celebrating another huge win after it stuck up a deal with an American rare diseases specialist worth nearly £400million in its latest investment.
Daily Express :: News Feed
ASTRAZENECA is celebrating another huge win after it stuck up a deal with an American rare diseases specialist worth nearly £400million in its latest investment.
Daily Express :: News Feed